Home » Topics » Regulatory » EMA

EMA
RSS

EMA accepts MAA for new insulin glargine biosimilar product

July 9, 2013

EMA approves positive opinion on Omeros' pediatric investigation plan

July 3, 2013

Procysbi receives positive CHMP recommendation

July 3, 2013

EMA gives Provenge a positive opinion

July 3, 2013

CHMP issues positive opinion on two variations for Velcade

July 2, 2013

Regorafenib recommended for approval in the E.U.

July 2, 2013

European CHMP recommends approval of two infliximab biosimilars

July 2, 2013

EMA recommends approval of two GSK cancer drugs

July 2, 2013

Approval of Lemtrada for relapsing remitting MS recommended in Europe

July 2, 2013

EryDex obtains orphan drug designation for ataxia telangiectasia in Europe

June 18, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Sun Pharma to acquire Merck spinoff Organon for $11.75B
BioWorld
Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of...